SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-085989
Filing Date
2023-08-01
Accepted
2023-08-01 06:01:54
Documents
22
Period of Report
2023-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322489d1_8k.htm   iXBRL 8-K 24634
2 EXHIBIT 99.1 tm2322489d1_ex99-1.htm EX-99.1 30326
6 GRAPHIC tm2322489d1_ex99-1img01.jpg GRAPHIC 161710
7 GRAPHIC tm2322489d1_ex99-1img02.jpg GRAPHIC 2052689
8 GRAPHIC tm2322489d1_ex99-1img03.jpg GRAPHIC 1432643
9 GRAPHIC tm2322489d1_ex99-1img04.jpg GRAPHIC 1168877
10 GRAPHIC tm2322489d1_ex99-1img05.jpg GRAPHIC 887340
11 GRAPHIC tm2322489d1_ex99-1img06.jpg GRAPHIC 1149073
12 GRAPHIC tm2322489d1_ex99-1img07.jpg GRAPHIC 1137283
13 GRAPHIC tm2322489d1_ex99-1img08.jpg GRAPHIC 1020748
14 GRAPHIC tm2322489d1_ex99-1img09.jpg GRAPHIC 1039937
  Complete submission text file 0001104659-23-085989.txt   14067374

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srne-20230801.xsd EX-101.SCH 3051
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20230801_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20230801_pre.xml EX-101.PRE 22383
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2322489d1_8k_htm.xml XML 3117
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 231129445
SIC: 2836 Biological Products, (No Diagnostic Substances)